Showing results (1-10 of 275) with videos related to
Sort By:
Pageof 28
Cell|December 2, 2017
Tumor Evolution: A Problem of HistocompatibilityNatalie I Vokes, Eliezer M Van AllenCancer Discovery|June 4, 2017
Toward Molecularly Driven Precision Medicine in Lung AdenocarcinomaDavid Liu, Natalie I Vokes, Eliezer M Van AllenJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 25, 2022
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung AdenocarcinomaNatalie I Vokes, Emily Chambers, Tom Nguyen, et al.Lung Cancer (Auckland, N.Z.)|December 9, 2021
The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung CancersNatalie I Vokes, Jianjun ZhangCancer Cell|April 15, 2025
New horizons at the interface of artificial intelligence and translational cancer researchJosephine Yates, Eliezer M Van AllenThe Urologic Clinics of North America|October 23, 2012
Moving toward personalized medicine in castration-resistant prostate cancerEliezer M Van Allen, Mark PomerantzCurrent Opinion in Immunology|June 3, 2016
Genomic determinants of cancer immunotherapyDiana Miao, Eliezer M Van AllenGenome Medicine|July 30, 2015
Next-generation sequencing to guide cancer therapyJeffrey Gagan, Eliezer M Van AllenCurrent Opinion in Urology|April 4, 2009
Novel secondary hormonal therapy in advanced prostate cancer: an updateEliezer M Van Allen, Charles J RyanCurrent Opinion in Urology|February 25, 2016
Precision medicine for advanced prostate cancerStephanie A Mullane, Eliezer M Van AllenPageof 28